JAZZ JAZZ

Jazz Pharmaceuticals Stock Price

126.11
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
126.11
Volume 0
Bid Price 125.45
Ask Price 129.45
News -
Day High

Low
117.64

52 Week Range

High
189.00

Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Jazz Pharmaceuticals PLC JAZZ NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 126.11 19:00:00
Open Price Low Price High Price Close Price Prev Close
126.11
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 126.11 USD

Period:

Draw Mode:

Jazz Pharmaceuticals PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.75B 61.47M 53.59M $ 2.36B $ -132.83M 4.23 -48.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -16.66k 5.10%

more financials information »

Jazz Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JAZZ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week121.30128.67119.64122.75527,1614.813.97%
1 Month135.67141.43117.64126.98643,471-9.56-7.05%
3 Months132.68146.66117.64132.16628,868-6.57-4.95%
6 Months180.00189.00117.64147.37664,180-53.89-29.94%
1 Year149.57189.00117.64156.25668,190-23.46-15.68%
3 Years140.89189.0086.88138.94618,374-14.78-10.49%
5 Years101.70189.0086.88142.48573,43424.4124.0%

Jazz Pharmaceuticals Description

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology. Jazz's product portfolio includes its lead drug, Xyrem, for narcolepsy, Sunosi for improving wakefulness in patients with excessive daytime sleepiness, Defitelio for severe veno-occlusive disease after stem cell transplant, Vyxeos for acute myeloid leukemia, and Zepzelca for small cell lung cancer.


Your Recent History
NASDAQ
JAZZ
Jazz Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.